Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer

NCT03192735 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Apatinib Combined
SOX
Neoadjuvant Therapy
Locally Advanced Gastric Cancer

Interventions

DRUG: ApatinibMesylateTablets

Sponsor

Chang-Ming Huang, Prof.